Nervotec is the world’s first provider of HaaS (Healthcare as a Service), a software only solution that measures and analyses physiological biomarkers remotely and contactlessly across multiple mobile platforms. In April 2022, Nervotec went into partnership with Prudential plc, a life and health insurance and asset management company in Asia and Africa, providing a mobile app in 17 markets and 11 languages. The app measures one’s vital signs, such as heart rate, heart rate variability, respiration rate and oxygen saturation levels simply by scanning their face with a mobile phone.

The Covid-19 pandemic had a profound effect on people’s mental health conditions in Japan, which has also drawn the attention of many Japan corporates on the importance of daily mental health management of their employees. Nervotec’s technology will be a good tool to obtain instant data that can be used to determine daily stress levels, emotional well-being and general fitness levels, which will indirectly affect one’s work efficiency.